International Journal of Peptide Research and Therapeutics
Scope & Guideline
Unlocking the Therapeutic Potential of Peptides.
Introduction
Aims and Scopes
- Therapeutic Applications of Peptides:
The journal investigates the use of peptides in various therapeutic contexts, including antimicrobial, anticancer, anti-inflammatory, and immunomodulatory applications. This includes the study of naturally occurring peptides, synthetic analogs, and engineered peptide constructs. - Peptide Design and Engineering:
Research published in this journal often focuses on the design, synthesis, and characterization of novel peptides. This includes the use of computational approaches, molecular docking, and structure-activity relationship studies to optimize peptide efficacy and specificity. - Mechanisms of Action:
The journal emphasizes understanding the biochemical and molecular mechanisms through which peptides exert their effects, including studies on signal transduction pathways, receptor interactions, and cellular responses. - Bioinformatics and Computational Modeling:
A significant portion of the research involves computational methods for predicting peptide interactions, designing peptide-based vaccines, and simulating the behavior of peptides in biological systems. - Natural Product Research:
The journal highlights the exploration of peptides derived from natural sources, including plants, animals, and microorganisms, and their potential therapeutic benefits. - Multidisciplinary Approaches to Peptide Research:
Research often integrates various scientific disciplines such as biochemistry, molecular biology, pharmacology, and materials science to advance the field of peptide therapeutics.
Trending and Emerging
- Antimicrobial Peptides (AMPs):
There is a growing body of research focused on the discovery, characterization, and application of antimicrobial peptides as alternatives to conventional antibiotics, particularly in addressing multidrug-resistant pathogens. - Peptide Vaccines:
The development of peptide-based vaccines, particularly in response to emerging infectious diseases such as COVID-19, has gained significant attention, with many studies exploring immunogenicity and efficacy. - Peptides in Cancer Therapy:
Research on peptides that target cancer cells, including their mechanisms of action and potential as therapeutic agents, is rapidly expanding, with a focus on novel delivery systems and combination therapies. - AI and Machine Learning in Peptide Design:
The integration of artificial intelligence and machine learning techniques in peptide design and optimization is emerging as a powerful tool, enhancing the ability to predict peptide interactions and therapeutic potential. - Natural and Synthetic Hybrid Peptides:
There is an increasing interest in hybrid peptides that combine properties of natural and synthetic peptides, aiming to enhance stability and efficacy for therapeutic applications. - Peptides for Neurological Disorders:
Research on the role of peptides in the treatment of neurological conditions, including neurodegenerative diseases and neuroinflammation, is on the rise, highlighting their therapeutic potential in the central nervous system.
Declining or Waning
- Traditional Antibiotics:
There appears to be a waning interest in the development of traditional peptide antibiotics as researchers increasingly focus on innovative approaches, such as multifunctional peptides or peptide-drug conjugates, to combat antibiotic resistance. - Peptides for General Health Supplements:
Research focused on the use of peptides exclusively for general health benefits or as dietary supplements is becoming less prominent, indicating a shift toward more targeted therapeutic applications. - Peptide-Based Diagnostics:
The exploration of peptides specifically for diagnostic applications has decreased, possibly as the field shifts towards integrated approaches that combine diagnostics with therapeutic interventions. - Basic Research in Peptide Chemistry:
While fundamental studies are essential, there is a noticeable decline in publications that focus solely on the basic chemistry of peptides without direct therapeutic implications, reflecting a trend toward more applied research.
Similar Journals
International Journal of Pharmaceutics
Elevating research to enhance therapeutic outcomes.The International Journal of Pharmaceutics, a prestigious publication from ELSEVIER, stands at the forefront of the pharmaceutical science field, exemplified by its impressive ranking of #15 out of 183 in Pharmacology, Toxicology, and Pharmaceutics, placing it in the 92nd percentile. Established in 1978, this journal has continuously provided a platform for researchers, professionals, and students to share groundbreaking discoveries and innovations in drug formulation, delivery systems, and pharmacokinetics. With a Q1 ranking in the 2023 category of Pharmaceutical Science, it underscores its significance in disseminating high-quality research that shapes clinical practices and enhances therapeutic outcomes. While the journal does not currently offer open access options, it remains accessible to subscribers through its publication based in Amsterdam, Netherlands, ensuring a broad reach within the scientific community. As it converges towards a vibrant future, the International Journal of Pharmaceutics continues to be an essential resource for anyone dedicated to advancing the field of pharmacy and drug development.
Peptide Science
Innovative insights into the world of peptide chemistry.Peptide Science, published by Wiley, is an esteemed journal dedicated to advancing the understanding of peptide chemistry and its applications across various scientific disciplines, including biochemistry, biophysics, and organic chemistry. Since its inception in 2018 and continuing through 2024, this journal has provided an essential platform for the dissemination of innovative research, engaging articles, and critical reviews. With an impressive Q3 ranking in the fields of Biochemistry and Biomaterials, and a Q2 status in Biophysics and Organic Chemistry as of 2023, Peptide Science acknowledges its integral role in addressing significant scientific challenges. This open-access journal ensures that findings are readily available to a global audience, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. The journal exemplifies excellence in scholarly communication, making it an essential resource for anyone interested in the intricate world of peptide research.
PROTEIN AND PEPTIDE LETTERS
Connecting researchers with the latest in molecular mechanisms.PROTEIN AND PEPTIDE LETTERS is a prominent peer-reviewed journal published by Bentham Science Publishers Ltd, specializing in the dynamic fields of biochemistry and structural biology. With an ISSN of 0929-8665 and a corresponding E-ISSN of 1875-5305, the journal has been a pivotal platform for researchers since its inception in 1994. Spanning various aspects of protein and peptide research, it aims to disseminate groundbreaking findings that enhance our understanding of molecular mechanisms and therapeutic applications. Although categorized in the Q3 quartile for biochemistry and medicine, and Q4 in structural biology within the 2023 metrics, it remains a valuable resource in the academic arena, offering insight into the latest research and advancements. As the journal converges towards its 2024 milestone, it continues to reflect the evolving landscape of molecular research. While it currently does not offer open access, the accessibility to its impactful content is essential for students, professionals, and researchers invested in these critical scientific disciplines.
CURRENT DRUG TARGETS
Pioneering Discoveries in Drug DevelopmentCURRENT DRUG TARGETS is a leading peer-reviewed journal dedicated to advancements in the fields of Clinical Biochemistry, Drug Discovery, Molecular Medicine, and Pharmacology. Published by Bentham Science Publishers Ltd, this esteemed journal has solidified its position in the academic community with a 2023 Q2 ranking in several categories, highlighting its influence and relevance in drug research and development. With an ISSN of 1389-4501 and E-ISSN 1873-5592, CURRENT DRUG TARGETS facilitates the dissemination of high-quality articles that explore novel therapeutic strategies and drug design principles. Catered to researchers, professionals, and students, the journal has a commitment to advancing knowledge while addressing contemporary challenges in pharmacological sciences. As it converges from 2000 to 2024, CURRENT DRUG TARGETS remains a vital resource in understanding the complexities of drug action and interaction, making it indispensable for anyone pursuing cutting-edge research in related disciplines.
Current Molecular Pharmacology
Connecting Researchers to Cutting-edge Pharmacological InsightsCurrent Molecular Pharmacology, published by Bentham Science Publishers, is a prominent journal focused on the dynamic fields of pharmacology, drug discovery, and molecular medicine. With an ISSN of 1874-4672 and an E-ISSN of 1874-4702, this journal aims to disseminate cutting-edge research and review articles that showcase innovative methodologies and groundbreaking findings from 2008 through 2024. Holding a respectable Q3 category ranking in Drug Discovery, Molecular Medicine, and Pharmacology for 2023, Current Molecular Pharmacology serves as an essential platform for both established researchers and emerging scholars to share their insights. The journal is indexed in Scopus with its relevant ranks catering to pharmacology and molecular biology, ensuring it reaches a wide array of professionals, researchers, and students in the field. As a contributor to advancing pharmacological sciences, this journal provides invaluable access to the latest advancements and fosters ongoing dialogue in molecular pharmacology, positioning itself as a key resource in the exploration of therapeutic agents and their interactions.
PEPTIDES
Advancing Knowledge in Biochemistry and BeyondPEPTIDES, published by Elsevier Science Inc, is a premier journal in the field of Biochemistry that has made a significant impact since its inception in 1980. With a current Impact Factor that places it in the Q2 and Q3 quartiles across multiple categories—including Cellular and Molecular Neuroscience and Endocrinology—this journal serves as a vital resource for researchers and professionals seeking to advance their understanding of peptide biology and its broad implications in health and disease. The journal's Scopus ranking reflects its relevance and esteemed contributions, ranking in the top percentiles in various biological disciplines. While currently not available as an open-access option, the depth of peer-reviewed research articles, reviews, and communications offered aims to push the boundaries of knowledge in physiology and molecular biology. As it converges towards 2024, PEPTIDES continues to be a beacon for innovative research that inspires the next generation of scientists.
Journal of Chemical Information and Modeling
Transforming Data into Chemical Insights.Journal of Chemical Information and Modeling is a premier scholarly publication dedicated to advancing the fields of chemical engineering, chemistry, and computer science applications. Published by the reputable American Chemical Society, this journal significantly contributes to the scientific community through innovative research and critical reviews that facilitate the understanding and application of chemical information. With an impressive impact factor and a distinguished ranking in multiple categories—such as Q1 in Chemical Engineering and Q1 in Chemistry—the journal is an indispensable resource for researchers and professionals alike. As open access is not currently available, the journal preserves a selective distribution model that ensures high-quality content is accessible to a dedicated audience. By exploring the intersections of data science and chemical informatics, the Journal of Chemical Information and Modeling fosters interdisciplinary collaboration and innovation, positioning itself as a leader in its field. Researchers, professionals, and students are encouraged to engage with this influential platform for the latest developments in chemical information science.
CURRENT PROTEIN & PEPTIDE SCIENCE
Bridging Knowledge Gaps in Protein and Peptide ScienceCURRENT PROTEIN & PEPTIDE SCIENCE, published by Bentham Science Publishers, is a pivotal journal dedicated to the dynamic and rapidly evolving fields of protein and peptide research. With an ISSN of 1389-2037 and an E-ISSN of 1875-5550, this esteemed journal serves as a platform for disseminating cutting-edge findings from various disciplines, including biochemistry, cell biology, and molecular biology. Recognized for its influence with a 2023 Scopus ranking placing it within the top quartiles of its categories—Q3 in Biochemistry, Q4 in Cell Biology, and Q2 in Medicine—the journal not only enhances the visibility of critical research but also supports the academic community in advancing our understanding of the molecular foundations of life. Established in 2000 and running through 2024, CURRENT PROTEIN & PEPTIDE SCIENCE is positioned to cater to the interests of researchers, professionals, and students alike, providing them with open access to vital knowledge that fuels innovation and scientific inquiry in the United Arab Emirates and beyond.
PROTEIN JOURNAL
Transforming Insights into Biomedical ApplicationsProtein Journal, published by Springer, stands as a significant academic resource in the fields of Analytical Chemistry, Biochemistry, Bioengineering, and Organic Chemistry. Since its inception in 1996, the journal has dedicated itself to the dissemination of high-quality research focused on protein chemistry and its biomedical applications. With an impressive impact reflected in its classification as a Q2 journal in Analytical Chemistry and Q3 in both Biochemistry and Bioengineering as of 2023, it provides an essential platform for researchers and practitioners to share their findings. The journal embraces the open-access model, enhancing accessibility to cutting-edge research. The Protein Journal is crucial for academicians, industry professionals, and students, catering to their need for rigorous scientific discourse and innovative discoveries in protein studies. With an established track record of converging over two decades of knowledge and research, it continues to influence and shape the advancements in this vital area of science.
JOURNAL OF PEPTIDE SCIENCE
Unveiling the science behind peptides and their potential.JOURNAL OF PEPTIDE SCIENCE, published by Wiley, is a vital resource for researchers and professionals in the fields of biochemistry, drug discovery, and molecular biology. Established in 1995 and encompassing research through 2024, this journal provides a platform for disseminating cutting-edge studies related to peptide synthesis, structure, function, and applications in therapeutics. Although it currently does not offer open access, its robust content has earned it a respectable Q3 ranking in several categories, including biochemistry and pharmacology, according to the latest metrics. Researchers will find significant insights linked to peptide chemistry and its implications in medical sciences, making the JOURNAL OF PEPTIDE SCIENCE an essential addition to academic libraries and for those passionate about peptide research and its potential breakthroughs.